PubRank

Richard K Russell

Author PubWeight™ 72.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012 16.13
2 Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008 4.05
3 Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 2009 3.82
4 Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2010 3.55
5 Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am J Hum Genet 2009 3.19
6 New genes in inflammatory bowel disease: lessons for complex diseases? Lancet 2006 2.72
7 Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition. Inflamm Bowel Dis 2014 2.59
8 NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut 2011 2.26
9 Anti-TNF, infliximab, and adalimumab can be effective in eosinophilic bowel disease. J Pediatr Gastroenterol Nutr 2013 2.08
10 Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum Mol Genet 2010 1.81
11 ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 2014 1.78
12 Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol 2012 1.54
13 Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr 2012 1.52
14 Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network. J Pediatr Gastroenterol Nutr 2016 1.39
15 Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol 2011 1.16
16 The genetics of inflammatory bowel disease. Am J Gastroenterol 2007 1.14
17 Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J Pediatr 2009 1.13
18 Genetics of the innate immune response in inflammatory bowel disease. Inflamm Bowel Dis 2007 1.05
19 The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study. PLoS One 2013 1.03
20 Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis 2011 1.02
21 Genetics of childhood-onset inflammatory bowel disease. Inflamm Bowel Dis 2011 1.00
22 Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease. Inflamm Bowel Dis 2009 0.98
23 The rising incidence of celiac disease in Scotland. Pediatrics 2013 0.97
24 A comprehensive evaluation of colonic mucosal isolates of Sutterella wadsworthensis from inflammatory bowel disease. PLoS One 2011 0.96
25 A case of posterior reversible encephalopathy syndrome in a child with Crohn's disease treated with Infliximab. J Crohns Colitis 2011 0.90
26 Two-stage genome-wide methylation profiling in childhood-onset Crohn's Disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci. Inflamm Bowel Dis 2014 0.89
27 A case of EBV driven haemophagocytic lymphohistiocytosis complicating a teenage Crohn's disease patient on azathioprine, successfully treated with rituximab. J Crohns Colitis 2012 0.86
28 Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy. Hum Mol Genet 2007 0.86
29 Growth in children receiving contemporary disease specific therapy for Crohn's disease. Arch Dis Child 2012 0.82
30 A prospective longitudinal study of growth and pubertal progress in adolescents with inflammatory bowel disease. Horm Res Paediatr 2014 0.82
31 Psychosocial functioning and health-related quality of life in paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011 0.82
32 Contribution of CARD15 variants in determining susceptibility to Crohn's disease in Sweden. Scand J Gastroenterol 2006 0.81
33 Novel susceptibility genes in inflammatory bowel disease. World J Gastroenterol 2006 0.81
34 A retrospective study showing maintenance treatment options for paediatric CD in the first year following diagnosis after induction of remission with EEN: supplemental enteral nutrition is better than nothing! BMC Gastroenterol 2014 0.81
35 Seronegative autoimmune hepatitis presenting after diagnosis of coeliac disease: a case report. Eur J Gastroenterol Hepatol 2009 0.81
36 Nutritional therapy for the treatment of pediatric Crohn's disease. Expert Rev Clin Immunol 2010 0.80
37 Serum C-reactive protein and CRP genotype in pediatric inflammatory bowel disease: influence on phenotype, natural history, and response to therapy. Inflamm Bowel Dis 2015 0.79
38 The epidemiology of anemia in pediatric inflammatory bowel disease: prevalence and associated factors at diagnosis and follow-up and the impact of exclusive enteral nutrition. Inflamm Bowel Dis 2013 0.78
39 Contribution of the IBD5 locus to Crohn's disease in the Swedish population. Scand J Gastroenterol 2007 0.78
40 Scottish outcomes for extra hepatic biliary atresia post-rationalisation of services. Arch Dis Child 2013 0.78
41 Endocrine therapy for growth retardation in paediatric inflammatory bowel disease. Paediatr Drugs 2014 0.77
42 Haplotype-tagging analysis of common variants of the IL23R gene demonstrates gene-wide extent of association with IBD. Inflamm Bowel Dis 2013 0.76
43 More pediatric NOD2/CARD data. Am J Gastroenterol 2004 0.76
44 ECCO-ESCP Consensus on Surgery for Crohn's Disease. J Crohns Colitis 2017 0.76
45 The validity of hospital discharge data. Eur J Gastroenterol Hepatol 2010 0.75
46 Variation in ICOSLG influences Crohn's disease susceptibility. Gut 2011 0.75
47 The routine use of fecal calprotectin in clinical pediatric practice: almost there or still issues to address? Am J Gastroenterol 2013 0.75
48 Real-Life Anti-Tumour Necrosis Factor Experience in > 500 Paediatric United Kingdom Inflammatory Bowel Disease Patients. J Pediatr Gastroenterol Nutr 2017 0.75
49 Faecal Calprotectin in Treated and Untreated Children With Coeliac Disease and Juvenile Idiopathic Arthritis. J Pediatr Gastroenterol Nutr 2016 0.75
50 Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN. Inflamm Bowel Dis 2016 0.75
51 Steroid Limbo in Acute Severe Ulcerative Colitis: How Low Can You Go? J Pediatr Gastroenterol Nutr 2016 0.75
52 Disease Status and Pubertal Stage Predict Improved Growth in Antitumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2017 0.75